Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STARS extend: Long-term Apraglutide in SBS
NCT05018286Phase 3Active, not recruiting
- Sponsor
- VectivBio
- Start
- Jul 2021
- Primary completion
- Oct 2027
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 18
01
Overview
A Phase 3 trial of apraglutide in short bowel syndrome (SBS), sponsored by VectivBio. Started Jul 2021; status: active, not recruiting.
02
Drugs
apraglutide
03
Conditions
short bowel syndrome (SBS)
Beyond the preview
Go deeper on NCT05018286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05018286.